ImmunityBio, Inc. IBRX Gain (loss) on disposal of assets
Gain (loss) on disposal of assets at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnInvestments.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s gain (loss) on disposal of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s gain (loss) on disposal of assets?
- ImmunityBio, Inc. (IBRX) reported gain (loss) on disposal of assets of $2.31M in Q1 2026.
- How has ImmunityBio, Inc.'s gain (loss) on disposal of assets changed year-over-year?
- ImmunityBio, Inc.'s gain (loss) on disposal of assets increased by 160.9% year-over-year, from $887K to $2.31M.
- What is the long-term trend for ImmunityBio, Inc.'s gain (loss) on disposal of assets?
- Over 4 years (2021 to 2025), ImmunityBio, Inc.'s gain (loss) on disposal of assets has grown at a 11.8% compound annual growth rate (CAGR), from -$4.1M to $6.41M.
- What does gain (loss) on disposal of assets mean?
- Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.